C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
260/239.1, 260/2
C07D 487/04 (2006.01) C07C 323/09 (2006.01) C07D 239/42 (2006.01)
Patent
CA 1051885
Abstract This invention relates to compounds of the formula Image I wherein m is 1 or 2, when m is 1, R occupies either the 4- or 5-positions of the starting 2-aminopyrimidine, but when R is halogen it occupies only position-5; whem m is 2, the two R-substituents occupy the 4- and 5-positions of the starting 2-aminopyrimidine, but only one of the two R-sub- stituents can be halogen and it must occupy the 5-position; R is the same of different and is hydrogen, F, Cl, Br, alkyl of from 1 to 4 carbons, benzyl, phenyl, or mono-substituted phenyl wherein the substituent is F, Cl, Br, I, alkyl of from 1 to 4 carbons, alkoxy of from 1 to 4 carbons, or tri- fluoromethyl; provided that when R is halogen, and m is 1, R occupies only the 5-position in the starting 2-aminopyrimidine; R' is hydrogen, F, Cl, Br, I, alkyl of from 1 to 4 carbons, alkoxy of from 1 to 4 carbons, alkylthio of from 1 to 4 carbons, alkylsulfonyl wherein the alkyl radical has from 1 to 4 carbons, phenyl, phenyloxy, sulfamoyl, dialkylamidosulfonyl wherein each alkyl radical has from 1 to 4 carbons, trifluoromethyl, mono-substituted phenyl or mono-substituted phenyloxy wherein the substituent is F, Cl, Br, I, alkyl of from 1 to 4 carbons, alkoxy of from 1 to 4 carbons or trifluoromethyl; n is 2 or 3, and pharmaceutically acceptable acid addition salts thereof, a process for preparing them and intermediates therefor. These compounds exhibit central nervous system stimulating properties and act as muscle relaxants.
203632
Petigara Ramesh B.
Yale Harry L.
LandOfFree
Therapeutic compounds and intermediates therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic compounds and intermediates therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic compounds and intermediates therefor will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-522060